Evidence map›Paper›PMID 36453199›Full record

ArticleMolecular medicine reports2023

Polysaccharides from

Jeong Moo Han, Ha-Yeon Song, Kwang-Il Kim, Woo Yong Park, Sang-Hyun Park, Eui-Baek Byun, Eui-Hong Byun

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jeong Moo HanAdvanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Jeollabuk‑do 56212, Republic of Korea.
Ha-Yeon SongAdvanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Jeollabuk‑do 56212, Republic of Korea.
Kwang-Il KimAdvanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Jeollabuk‑do 56212, Republic of Korea.
Woo Yong ParkDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Sang-Hyun ParkDepartment of Food Science and Technology, Kongju National University, Yesan‑eup, Chungcheongnam‑do 340‑800, Republic of Korea.
Eui-Baek ByunAdvanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Jeollabuk‑do 56212, Republic of Korea.
Eui-Hong ByunDepartment of Food Science and Technology, Kongju National University, Yesan‑eup, Chungcheongnam‑do 340‑800, Republic of Korea.
Korea Atomic Energy Research Institute · KRKongju National University · KRKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin is a prominent chemotherapeutic agent that can induce significant damage to normal cells. Therefore, it is important to develop agents that protect normal cells without influencing the chemotherapeutic effect of cisplatin. The present study was conducted to explore the protective effects of

Indexed as

AnnonaLung NeoplasmsCisplatinMacrophagesMitochondriaPlant LeavesPolysaccharidesReactive Oxygen SpeciesCisplatinPolysaccharidesReactive Oxygen SpeciesAnnona muricatacisplatincytoprotectionmacrophagepolysaccharidestoxic side effect

Identifiers

PMID36453199
PMCPMC9743389
OpenAlexW4310603856

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.